A Unified Approach to the Important Protein Kinase Inhibitor Balanol and a Proposed Analogue

Overview

Journal Beilstein J Org Chem

Specialty Chemistry

Date 2014 Jan 24

PMID 24454570

Citations 1

Authors

Tapan Saha

Ratnava Maitra

Shital K Chattopadhyay

Affiliations

Soon will be listed here.

Abstract

A common approach to the important protein kinase inhibitor (-)-balanol and an azepine-ring-modified balanol derivative has been developed using an efficient fragment coupling protocol which proceeded in good overall yield.

Citing Articles

Total Synthesis of Asperphenins A and B.

Yan J, Cheng Y, Chen J, Ratnayake R, Dang L, Luesch H Org Lett. 2018; 20(19):6170-6173.

PMID: 30232896 PMC: 7331471. DOI: 10.1021/acs.orglett.8b02652.

References

Hu H, Mendoza J, Lowden C, Ballas L, Janzen W . Synthesis and protein kinase C inhibitory activities of balanol analogues with modification of 4-hydroxybenzamido moiety. Bioorg Med Chem. 1997; 5(9):1873-82. DOI: 10.1016/s0968-0896(97)00125-9. View

Furstner A, Thiel O . Formal total synthesis of (-)-balanol: concise approach to the hexahydroazepine segment based on RCM. J Org Chem. 2000; 65(6):1738-42. DOI: 10.1021/jo991611g. View

Lai Y, Mendoza J, Jagdmann Jr G, Menaldino D, Biggers C, Heerding J . Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety. J Med Chem. 1997; 40(2):226-35. DOI: 10.1021/jm960497g. View

Roffey J, Rosse C, Linch M, Hibbert A, McDonald N, Parker P . Protein kinase C intervention: the state of play. Curr Opin Cell Biol. 2009; 21(2):268-79. DOI: 10.1016/j.ceb.2009.01.019. View

NISHIZUKA Y . Studies and perspectives of protein kinase C. Science. 1986; 233(4761):305-12. DOI: 10.1126/science.3014651. View

Hofmann J . Protein kinase C isozymes as potential targets for anticancer therapy. Curr Cancer Drug Targets. 2004; 4(2):125-46. DOI: 10.2174/1568009043481579. View

Koide K, Bunnage M, Gomez Paloma L, Kanter J, Taylor S, Brunton L . Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol. Chem Biol. 1995; 2(9):601-8. DOI: 10.1016/1074-5521(95)90124-8. View

Ohshima S, Yanagisawa M, Katoh A, Fujii T, Sano T, Matsukuma S . Fusarium merismoides Corda NR 6356, the source of the protein kinase C inhibitor, azepinostatin. Taxonomy, yield improvement, fermentation and biological activity. J Antibiot (Tokyo). 1994; 47(6):639-47. DOI: 10.7164/antibiotics.47.639. View

Trost B, Fandrick D, Brodmann T, Stiles D . Dynamic kinetic asymmetric allylic amination and acyl migration of vinyl aziridines with imido carboxylates. Angew Chem Int Ed Engl. 2007; 46(32):6123-5. DOI: 10.1002/anie.200700835. View

10.

Srivastava A, Panda G . Total synthesis of (-)-balanol, all stereoisomers, their N-tosyl analogues, and fully protected ophiocordin: an easy route to hexahydroazepine cores from garner aldehydes. Chemistry. 2008; 14(15):4675-88. DOI: 10.1002/chem.200701991. View

11.

Breitenlechner C, Wegge T, Berillon L, Graul K, Marzenell K, Friebe W . Structure-based optimization of novel azepane derivatives as PKB inhibitors. J Med Chem. 2004; 47(6):1375-90. DOI: 10.1021/jm0310479. View

12.

NISHIZUKA Y . Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 1995; 9(7):484-96. View

13.

Narayana N, Diller T, Koide K, Bunnage M, Nicolaou K, Brunton L . Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase. Biochemistry. 1999; 38(8):2367-76. DOI: 10.1021/bi9820659. View

14.

Mochly-Rosen D, Das K, Grimes K . Protein kinase C, an elusive therapeutic target?. Nat Rev Drug Discov. 2012; 11(12):937-57. PMC: 3760692. DOI: 10.1038/nrd3871. View

15.

Wong C, Bairy S . Drug design for protein kinases and phosphatases: flexible-receptor docking, binding affinity and specificity, and drug-binding kinetics. Curr Pharm Des. 2012; 19(26):4739-54. DOI: 10.2174/1381612811319260006. View

16.

Newton A . Protein kinase C: structure, function, and regulation. J Biol Chem. 1995; 270(48):28495-8. DOI: 10.1074/jbc.270.48.28495. View

17.

Storm J, Andersson C . An organoiron approach to the benzophenone appendage of the protein kinase C inhibitor balanol. Org Lett. 2000; 1(9):1451-3. DOI: 10.1021/ol9910060. View

18.

Unthank M, Hussain N, Aggarwal V . The use of vinyl sulfonium salts in the stereocontrolled asymmetric synthesis of epoxide- and aziridine-fused heterocycles: application to the synthesis of (-)-balanol. Angew Chem Int Ed Engl. 2006; 45(42):7066-9. DOI: 10.1002/anie.200602782. View

19.

Lampe J, Hughes P, Biggers C, Smith S, Hu H . Total Synthesis of (-)- and (+)-Balanol(1). J Org Chem. 1996; 61(14):4572-4581. DOI: 10.1021/jo952280k. View

20.

Teicher B . Protein kinase C as a therapeutic target. Clin Cancer Res. 2006; 12(18):5336-45. DOI: 10.1158/1078-0432.CCR-06-0945. View